Greater than 97% as determined by RP-HPLC.
Liraglutide peptide is a single, non-glycosylated polypeptide chain containing 31 amino acids, having a molecular mass of 3751 Dalton and a Molecular formula of C172H265N43O51.
H-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(γ-Glu-palmitoyl)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-OH
Liraglutide works by increasing the amount of insulin produced by the pancreas when blood sugar levels are high. It also reduces the amount of glucagon, a hormone that increases blood sugar levels, produced by the pancreas . Additionally, liraglutide slows down the emptying of the stomach, which helps to reduce appetite and food intake .
Type 2 Diabetes Mellitus: Liraglutide is used as a second-line therapy for type 2 diabetes, particularly when first-line treatments like metformin are not sufficient . It helps to control blood sugar levels and has been shown to reduce the risk of cardiovascular complications associated with diabetes .
Chronic Obesity: Under the brand name Saxenda, liraglutide is used for weight management in individuals with obesity. It helps to reduce appetite and increase feelings of fullness, leading to reduced food intake and weight loss .
Liraglutide is synthesized using recombinant DNA technology. The production process involves the insertion of the gene encoding the GLP-1 analog into a host organism, typically Escherichia coli or Saccharomyces cerevisiae. The host organism then produces the GLP-1 analog, which is subsequently purified and formulated into the final product .